The cancer-treatment.net is a California based non-profit charity. The website is maintained by Jay Kulsh, an independent scientist, and his associates. While doing graduate work at the Chemistry & Biochemistry department of University of California, Jay Kulsh got interested in the enzyme Ribonucleotide Reductase (RnR) due to its paramount importance in cell division.

Later, even when not associated with any scientific or medical institution, Jay Kulsh followed the scientific progress made in understanding the nature and role of enzyme RnR, especially as it relates to cancerous growth. In 1990s, he found enough evidence to conclude that the active-site of enzyme RnR is the primary target of various class of carcinogenic agents.

This further led him to observe that:

Chemicals cause cancer… Chemicals are used to treat cancer.

Radiation causes cancer… Radiation is used to treat cancer.

Electricity (alternating current at steep voltages) may cause cancer… Electricity (direct current at low voltages) would heal cancer.

Jay Kulsh built and improved devices suitable for the treatment of cancer and contacted cancer patients over the years, where they were able to establish efficacy of this treatment on humans. This cancer therapy is based on blocking a critical enzyme in DNA synthesis as well as in cell growth, Ribonucleotide Reductase (RnR).

Gentle Electrotherapy to Inhibit Pivotal Enzyme (GEIPE) protocol is a non-surgical cancer treatment and is available globally for near-surface tumours (all skin cancers, some breast and prostate cancers) as a home-remedy, initially supervised via video conference. Although scientific, this treatment may be called complimentary, holistic, natural or alternative.

The revolutionary GEIPE cancer therapy is not patentable and thus remains untouchable. The mission of this website is to make cancer patients aware of this non-toxic and effective therapy so that one day, through collective efforts, the current gloomy landscape of cancer treatments may be transformed.

Read more on Scientific Basis of GEIPE Cancer Therapy